Benchmark Company Reiterates Hold Rating, $17 PT on Vascular Solutions on Announced Product Recall

In a report published Monday, Benchmark Company analyst James Terwilliger reiterated a Hold rating and $17.00 price target on Vascular Solutions

. In the report, Terwilliger noted, “After the close of business on Friday, March 15, 2013, VASC announced that the company has initiated a nationwide recall of their Guardian®II and Guardian®II NC hemostasis valves used in catheterization procedures. Specific lots of the products have been recalled because they pose a slight risk of air leakage that may lead to an air embolism, which could result in serious injury or death. We believe that it is a manufacturing issue with the product and we also believe that no patients have been harmed.” Vascular Solutions closed on Friday at $15.00.